Thursday - July 30, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to NewSelf
March 04, 2026
WASHINGTON, March 4 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to NewSelf Limited from its Center for Drug Evaluation and Research:

* * *

Recipient: NewSelf Limited dba NewSelf, 521 5th Avenue, 17th Floor, New York, NY 10175, United States, legal@newself.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER

NewSelf:< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products